Covered recipient · General Payments record
JOSE ARCINIEGA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$5,219.52
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,488.80 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | $374.95 | 3 |
| Lilly USA, LLC | $354.11 | 5 |
| Novo Nordisk AS | $243.62 | 2 |
| Amgen Inc. | $219.75 | 2 |
| Acerta Pharma LLC | $121.82 | 1 |
| CeQur Corporation | $96.43 | 1 |
| DEXCOM, INC. | $78.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $123.63 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111518777 | CMS |
| Amgen Inc. | $96.12 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111518779 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.82 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105727265 | CMS |
| CeQur Corporation | $96.43 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126844844 | CMS |
| Dexcom, Inc. | $78.12 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153310859 | CMS |
| Lilly USA, LLC | $67.32 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135083712 | CMS |
| Lilly USA, LLC | $70.39 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135073895 | CMS |
| Lilly USA, LLC | $78.53 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135101074 | CMS |
| Lilly USA, LLC | $78.76 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135082444 | CMS |
| Lilly USA, LLC | $59.11 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135080086 | CMS |
| Novo Nordisk Inc | $121.81 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096914686 | CMS |
| Novo Nordisk Inc | $121.81 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096803611 | CMS |
| Phathom Pharmaceuticals, Inc. | $124.99 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151035947 | CMS |
| Phathom Pharmaceuticals, Inc. | $124.97 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151035949 | CMS |
| Phathom Pharmaceuticals, Inc. | $124.99 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151035951 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.